IN2012DN03128A - - Google Patents

Download PDF

Info

Publication number: IN2012DN03128A
Authority: IN; India
Prior art keywords: compositions; eye; active ingredient; treatment; group
Prior art date: 2009-12-14

Application number

Other languages

English (en)

Inventor

Bastian Theisinger

Sonja Theisinger

Bernhard Gunther

Original Assignee

Novaliq Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-14

Filing date

2010-12-13

Publication date

2015-09-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41731659&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2012DN03128(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-12-13 Application filed by Novaliq Gmbh filed Critical Novaliq Gmbh

2015-09-18 Publication of IN2012DN03128A publication Critical patent/IN2012DN03128A/en

Links

239000000203 mixture Substances 0.000 abstract 2
208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
206010013774 Dry eye Diseases 0.000 abstract 1
208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
150000001335 aliphatic alkanes Chemical class 0.000 abstract 1
229960003444 immunosuppressant agent Drugs 0.000 abstract 1
239000003018 immunosuppressive agent Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Ophthalmology & Optometry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IN3128DEN2012 2009-12-14 2010-12-13 IN2012DN03128A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP09015423A EP2335735A1 (fr)	2009-12-14	2009-12-14	Composition pharmaceutique pour le traitement de la kératoconjonctivite sèche
PCT/EP2010/069495 WO2011073134A1 (fr)	2009-12-14	2010-12-13	Composition pharmaceutique pour le traitement du syndrome de l'oeil sec

Publications (1)

Publication Number	Publication Date
IN2012DN03128A true IN2012DN03128A (fr)	2015-09-18

Family

ID=41731659

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN3128DEN2012 IN2012DN03128A (fr)	2009-12-14	2010-12-13

Country Status (15)

Country	Link
US (1)	US8614178B2 (fr)
EP (2)	EP2335735A1 (fr)
JP (5)	JP5663595B2 (fr)
KR (2)	KR101722039B1 (fr)
CN (1)	CN102652022B (fr)
AU (1)	AU2010333039B2 (fr)
BR (3)	BR122020020872B1 (fr)
CA (2)	CA2776860C (fr)
DK (1)	DK2512515T3 (fr)
ES (1)	ES2449308T3 (fr)
IN (1)	IN2012DN03128A (fr)
MX (1)	MX2012006720A (fr)
PL (1)	PL2512515T3 (fr)
PT (1)	PT2512515E (fr)
WO (1)	WO2011073134A1 (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2437684B1 (fr)	2009-06-03	2022-06-15	ForSight Vision5, Inc.	Distribution de médicament de segment antérieur
ES2564502T3 (es)	2010-03-17	2016-03-23	Novaliq Gmbh	Composición farmacéutica para el tratamiento de la presión intraocular aumentada
EP2444063A1 (fr)	2010-10-20	2012-04-25	Novaliq GmbH	Compositions pharmaceutiques liquides pour l'administration de principes actifs
EP2462921A1 (fr)	2010-11-11	2012-06-13	Novaliq GmbH	Compositions pharmaceutiques liquides pour le traitement d'une maladie de la chambre postérieure de l'oeil
CN103561724B (zh)	2011-05-25	2016-06-29	诺瓦利克有限责任公司	给药给甲的药物组合物
JP6039145B2 (ja)	2011-05-25	2016-12-07	ノバリックゲーエムベーハー	半フッ化アルカンを基礎にした局所薬学的組成物
PT2806886T (pt)	2012-01-23	2017-03-24	Novaliq Gmbh	Composições de proteínas estabilizadas baseadas em alcanos semifluorados
MX363182B (es) *	2012-09-12	2019-03-13	Novaliq Gmbh	Composiciones que comprenden mezclas de alcanos semifluorados.
EP2895144B1 (fr)	2012-09-12	2017-01-11	Novaliq GmbH	Compositions d'alcane semifluoré
PL2708228T3 (pl)	2012-09-12	2018-11-30	Novaliq Gmbh	Kompozycje do przemywania oczu
EP2730291A1 (fr) *	2012-11-09	2014-05-14	Fluoron Gmbh	Composition de tamponnade interne
US10172789B2 (en)	2013-01-24	2019-01-08	Palvella Therapeutics Llc	Compositions for transdermal delivery of mTOR inhibitors
JP6304475B2 (ja) *	2013-01-31	2018-04-04	ロート製薬株式会社	点眼剤
TWI623313B (zh) *	2013-03-13	2018-05-11	Santen Pharmaceutical Co Ltd	瞼板腺功能障礙之治療劑
DK3024484T3 (en)	2013-07-23	2018-10-08	Novaliq Gmbh	STABILIZED ANTIBODY COMPOSITIONS
US20160243291A1 (en) *	2013-10-15	2016-08-25	Forsight Vision5, Inc.	Formulations and Methods for Increasing or Reducing Mucus
US20200237859A1 (en)	2019-01-25	2020-07-30	Newport Research, Inc.	Aqueous suspensions of cyclosporin
US11324800B2 (en)	2015-01-15	2022-05-10	Wellspring Ophthalmics, Inc.	Aqueous suspensions of cyclosporin
EP3283004A4 (fr)	2015-04-13	2018-12-05	Forsight Vision5, Inc.	Composition d'insert oculaire d'agent pharmaceutiquement actif cristallin ou semi-cristallin
US11013403B2 (en) *	2015-09-29	2021-05-25	The Regents Of The University Of California	Methods of diagnosing diseases of mucosal surfaces
US20170087100A1 (en)	2015-09-30	2017-03-30	Novaliq Gmbh	Semifluorinated compounds and their compositions
EP3722274B1 (fr) *	2015-09-30	2023-06-07	Novaliq GmbH	2-perfluorobutyl pentane pour administration ophtalmique
DK3442480T3 (da)	2016-06-23	2020-01-13	Novaliq Gmbh	Fremgangsmåde til topisk indgivelse
KR102614858B1 (ko)	2016-09-22	2023-12-18	노바리크 게엠베하	안검염 치료에 사용되는 약제학적 조성물
AU2017329983B2 (en) *	2016-09-23	2022-05-05	Novaliq Gmbh	Ophthalmic compositions comprising ciclosporin
CN109803650A (zh) *	2016-09-28	2019-05-24	诺瓦利克有限责任公司	包含大麻素受体结合配体的组合物
WO2018114557A1 (fr) *	2016-12-22	2018-06-28	Novaliq Gmbh	Compositions comprenant du tacrolimus pour le traitement de maladies oculaires inflammatoires intraoculaires
MX381639B (es) *	2016-12-23	2025-03-13	Novaliq Gmbh	Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
WO2018129364A1 (fr)	2017-01-06	2018-07-12	Palvella Therapeutics Llc	Compositions anhydres d'inhibiteurs de mtor et méthodes d'utilisation
PL3612228T3 (pl)	2017-04-21	2024-04-08	Dermaliq Therapeutics, Inc.	Kompozycje jodu
US10717691B2 (en)	2017-05-05	2020-07-21	Novaliq Gmbh	Process for the production of semifluorinated alkanes
US11278503B2 (en)	2017-05-12	2022-03-22	Novaliq Gmbh	Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
JP7814839B2 (ja)	2017-09-27	2026-02-17	ノバリックゲーエムベーハー	眼疾患の治療に使用するためのラタノプロストを含む眼科用組成物
CN111182893A (zh)	2017-10-04	2020-05-19	诺瓦利克有限责任公司	包含f6h8的眼用组合物
US11576893B2 (en)	2018-03-02	2023-02-14	Novaliq Gmbh	Pharmaceutical compositions comprising nebivolol
AU2019246035B2 (en)	2018-03-28	2024-07-18	Novaliq Gmbh	Pharmaceutical composition comprising timolol
JP7855312B2 (ja)	2018-04-27	2026-05-08	ノバリックゲーエムベーハー	緑内障の治療のためのタフルプロストを含む眼科用組成物
EP3817743A4 (fr)	2018-07-02	2022-07-06	Palvella Therapeutics, Inc.	Compositions anhydres d'inhibiteurs de mtor et méthodes d'utilisation
EP3852734A1 (fr)	2018-09-22	2021-07-28	Novaliq GmbH	Compositions ophtalmiques pour le traitement de lésions de surface oculaire et de symptômes de sécheresse
WO2020064549A1 (fr)	2018-09-27	2020-04-02	Novaliq Gmbh	Réparation de la barrière lipidique
CA3112031A1 (fr)	2018-10-12	2020-04-16	Novaliq Gmbh	Composition ophtalmique pour le traitement d'une maladie oculaire seche
CN113518619A (zh) *	2019-01-21	2021-10-19	诺瓦利克有限责任公司	用于治疗眼部新生血管形成的药物组合物
EP3923907B1 (fr)	2019-02-13	2024-09-25	Novaliq GmbH	Compositions et procédés pour le traitement de la néovascularisation oculaire
WO2020239646A1 (fr)	2019-05-24	2020-12-03	Novaliq Gmbh	Composition ophtalmique pour le traitement d'une allergie oculaire
CN114449999A (zh)	2019-09-06	2022-05-06	诺瓦利克有限责任公司	用于治疗葡萄膜炎的眼用组合物
WO2021048803A1 (fr)	2019-09-13	2021-03-18	Minas Coroneo	Distributeur de gouttes oculaires
EP3861857A1 (fr) *	2020-02-07	2021-08-11	Novaliq GmbH	Composition antiparasitaire
WO2021191273A1 (fr)	2020-03-24	2021-09-30	Hovione Scientia Limited	Compositions destinées à être utilisées dans le traitement d'un dysfonctionnement de la glande de meibomius
US11191751B1 (en) *	2020-10-08	2021-12-07	Ads Therapeutics Llc	Topical ophthalmological atropine free base compositions
EP4606396A4 (fr) *	2022-11-11	2025-12-03	Cardio Navi Medtech Wuhan Co Ltd	Solution d'enrobage pour ballonnet enrobé de médicament, matériau d'enrobage, ballonnet enrobé de médicament, son procédé de préparation et son utilisation
EP4665377A1 (fr) *	2023-02-13	2025-12-24	Novaliq GmbH	Composition ophtalmique pour préparation de chirurgie oculaire chez des patients atteints d'une maladie de surface oculaire
AU2023270196B2 (en) *	2023-11-20	2025-06-26	Dyer, Gordon Wayne DR	Method of Arthropod Egress
WO2026104414A1 (fr) *	2024-11-12	2026-05-21	Dermaliq Therapeutics Gmbh	Compositions topiques pour le traitement de l'alopécie en aires

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4839342A (en)	1987-09-03	1989-06-13	University Of Georgia Research Foundation, Inc.	Method of increasing tear production by topical administration of cyclosporin
WO1989001772A1 (fr)	1987-09-03	1989-03-09	University Of Georgia Research Foundation, Inc.	Composition de cyclosporine oculaire
US5874481A (en) *	1995-06-07	1999-02-23	Alliance Pharmaceutical Corp.	Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
DE19536504C2 (de) *	1995-09-29	1999-09-23	H Meinert	Verwendung fluorierter Alkane
DE19861012A1 (de) *	1998-03-18	1999-09-30	Pharm Pur Gmbh	Behandlungsmittel für die Ophthalmologie
CZ20013769A3 (cs) *	1999-04-30	2002-03-13	Sucampo Ag	Činidlo pro léčbu suchého oka
DE19938668B4 (de) *	1999-08-14	2006-01-26	Bausch & Lomb Inc.	Tränenersatzmittel
US20030018044A1 (en) *	2000-02-18	2003-01-23	Peyman Gholam A.	Treatment of ocular disease
US20080019926A1 (en) *	2004-04-19	2008-01-24	Marie-Pierre Krafft	Lung Surfactant Supplements
EP1763336A1 (fr) *	2004-06-08	2007-03-21	Ocularis Pharma, Inc.	Compositions ophtalmiques hydrophobes et leurs procedes d'utilisation
DE102007055046A1 (de) *	2007-11-19	2009-05-28	Fluoron Gmbh	Infusionslösung
PL2110126T3 (pl)	2008-04-18	2012-04-30	Novaliq Gmbh	Zastosowanie do inhalacji i zakraplania semifluorowanych alkanów jako nośników substancji aktywnych w strefie wewnątrzpłucnej

2009
- 2009-12-14 EP EP09015423A patent/EP2335735A1/fr not_active Withdrawn
2010
- 2010-12-13 PT PT107907750T patent/PT2512515E/pt unknown
- 2010-12-13 KR KR1020167023214A patent/KR101722039B1/ko active Active
- 2010-12-13 CA CA2776860A patent/CA2776860C/fr active Active
- 2010-12-13 JP JP2012542577A patent/JP5663595B2/ja active Active
- 2010-12-13 AU AU2010333039A patent/AU2010333039B2/en active Active
- 2010-12-13 PL PL10790775T patent/PL2512515T3/pl unknown
- 2010-12-13 US US13/513,886 patent/US8614178B2/en active Active
- 2010-12-13 CN CN201080055507.7A patent/CN102652022B/zh active Active
- 2010-12-13 ES ES10790775.0T patent/ES2449308T3/es active Active
- 2010-12-13 CA CA2941956A patent/CA2941956C/fr active Active
- 2010-12-13 EP EP10790775.0A patent/EP2512515B1/fr active Active
- 2010-12-13 DK DK10790775.0T patent/DK2512515T3/en active
- 2010-12-13 BR BR122020020872-4A patent/BR122020020872B1/pt active IP Right Grant
- 2010-12-13 WO PCT/EP2010/069495 patent/WO2011073134A1/fr not_active Ceased
- 2010-12-13 IN IN3128DEN2012 patent/IN2012DN03128A/en unknown
- 2010-12-13 KR KR1020127018066A patent/KR101652714B1/ko active Active
- 2010-12-13 BR BR122017018955-7A patent/BR122017018955B1/pt active IP Right Grant
- 2010-12-13 MX MX2012006720A patent/MX2012006720A/es active IP Right Grant
- 2010-12-13 BR BR112012014190A patent/BR112012014190B8/pt active IP Right Grant
2014
- 2014-10-01 JP JP2014203406A patent/JP6096731B2/ja active Active
2016
- 2016-12-22 JP JP2016248533A patent/JP6397472B2/ja active Active
2018
- 2018-08-31 JP JP2018163569A patent/JP2019006803A/ja active Pending
- 2018-12-28 JP JP2018248700A patent/JP6731039B2/ja active Active

Also Published As

Publication number	Publication date
WO2011073134A1 (fr)	2011-06-23
PT2512515E (pt)	2014-03-04
BR112012014190B8 (pt)	2021-05-25
JP6096731B2 (ja)	2017-03-15
AU2010333039B2 (en)	2014-08-28
JP6397472B2 (ja)	2018-09-26
BR112012014190B1 (pt)	2021-03-02
KR20120115977A (ko)	2012-10-19
CA2941956C (fr)	2018-09-04
AU2010333039A1 (en)	2012-07-12
EP2512515B1 (fr)	2013-12-25
JP2019070003A (ja)	2019-05-09
MX2012006720A (es)	2012-07-30
JP2019006803A (ja)	2019-01-17
KR101722039B1 (ko)	2017-03-31
JP6731039B2 (ja)	2020-07-29
US8614178B2 (en)	2013-12-24
BR122020020872B1 (pt)	2021-09-08
JP2013513586A (ja)	2013-04-22
BR122017018955B1 (pt)	2022-03-08
KR101652714B1 (ko)	2016-09-01
PL2512515T3 (pl)	2014-05-30
EP2335735A1 (fr)	2011-06-22
BR112012014190A2 (pt)	2016-05-31
CA2776860A1 (fr)	2011-06-23
CA2776860C (fr)	2016-10-25
JP2015028064A (ja)	2015-02-12
CA2941956A1 (fr)	2011-06-23
US20120244177A1 (en)	2012-09-27
JP2017078086A (ja)	2017-04-27
KR20160105533A (ko)	2016-09-06
HK1172269A1 (en)	2013-04-19
DK2512515T3 (en)	2014-03-10
ES2449308T3 (es)	2014-03-19
EP2512515A1 (fr)	2012-10-24
JP5663595B2 (ja)	2015-02-04
CN102652022A (zh)	2012-08-29
CN102652022B (zh)	2014-12-17

Publication	Publication Date	Title
MX2012006720A (es)	2012-07-30	Composicion farmceutica para el tratamiento de sindrome del ojo seco.
MX389597B (es)	2025-03-20	Inhibidores de cdk2/4/6 de piridopirimidinona.
WO2014047427A3 (fr)	2015-07-16	Inhibiteurs de la mcl-1 à base de benzofurane, de benzothiophène et d'indole substitués
NZ708593A (en)	2018-01-26	Novel pyrazole derivative
MY175800A (en)	2020-07-09	Combination treatment of cancer
EP4342540A3 (fr)	2024-05-29	Dérivés hétérocyclyle substitués en tant qu'inhibiteurs de cdk
EP4292662A3 (fr)	2024-02-21	Inhibiteurs d'indoles mcl-1 substitués
WO2015070224A3 (fr)	2015-08-13	Polythérapie comprenant un inhibiteur de mdm2 et un ou plusieurs principes pharmaceutiquement actifs supplémentaires pour le traitement de cancers
CU20160109A7 (es)	2017-02-02	Compuestos de indazol como inhibidores de irak4
MX2016011468A (es)	2017-01-23	Inhibidores de calicreína plasmática humana.
DOP2019000275A (es)	2019-11-15	Nuevos derivados de pirazol bicíclicos
MX2013012776A (es)	2013-11-21	Inhibidores de la tirosina cinasa de bazo que contienen aminopiridina.
EP4403552A3 (fr)	2024-10-16	Inhibiteurs de hsp90 c-terminaux
UA103930C2 (ru)	2013-12-10	Соединения и композиция для лечения паразитарных болезней
EP4414376A3 (fr)	2024-11-06	Nouveau depsipeptide et ses utilisations
CO6602152A2 (es)	2013-01-18	En respuesta al requerimiento de pago de reivindicaciones adicionales a las 10 primeras,presenta nuevo capítulo reivindicatorio y paga.
EP3216798A3 (fr)	2017-10-25	Composés kétolides
MX341220B (es)	2016-08-10	Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
EP4299126A3 (fr)	2024-04-03	Modulateurs allostériques positifs au gaba restreints au système nerveux périphérique pour le traitement du syndrome du côlon irritable et autres affections du système nerveux périphérique
PH12013500644A1 (en)	2013-05-20	Co-crystals and salts of ccr3-inhibitors
MX2024010625A (es)	2024-09-05	Compuestos antibioticos, metodos de fabricacion de los mismos, composiciones farmaceuticas conteniendo los mismos y usos de los mismos.
CL2012003521A1 (es)	2013-02-15	Derivado piperidino (r)-n-((r)-1-((3s-4s)-4-(4-clorofenil)-3,4-dihidroxi-3-metilpiperidin-1-il)-3-metil-1-oxobutan-2-il)-3,3-difluorociclopentanocarboxamida, modulador receptor quimiocinas; composicion farmaceutica; y uso del compuesto y su composicion en enfermedades inflamatorias y autoinmunitarias, entre otras.
MX2020012989A (es)	2021-02-16	Agente terapeutico para la fibrosis.
IN2014CN02908A (fr)	2015-07-03
NZ737892A (en)	2018-09-28	Muscarinic m1 receptor positive allosteric modulators